Teleflex Incorporated (Limerick, PA) announced that it has received CE Mark approval to market the company’s Arrow GPSCath balloon dilatation catheters in the European Union. The Arrow GPSCath catheter is designed as a dual-function device that incorporates the company’s VisioValve injection system, which enables interventionists to perform high-pressure angioplasty and inject physician-specified fluids, such as contrast, while maintaining guidewire position.